GSK Investigational Site

Žilina 012 07

0 studies enrolling now · 4 studies all time

What they study most

Chemotherapy-Induced Nausea and Vomiting, Nausea, Nausea and Vomiting, Chemotherapy-Induced, Prostatic Hyperplasia, Pulmonary Disease, Chronic Obstructive, Vomiting

Studies at this site

• A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment — Completed
• Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy — Completed
• Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting — Completed